Thus, it was not unexpected to find that CD4+ T cells in patients with SCCHN were characterised by the loss of CCR7 and L-selectin surface molecules, which are functionally associated with cell migration into tissues and serve as phenotypic markers for distinct stages of lymphocyte differentiation, respectively. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.